NCT03181256View on ClinicalTrials.gov

Early Detection of Lung Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

December 14, 2017

Primary Completion Date

November 30, 2023

Study Completion Date

December 1, 2025

Conditions
Lung Cancer
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of sputum

PROCEDURE

Biospecimen collection

Undergo collection of nasal epithelium

PROCEDURE

Biospecimen collection

Undergo collection of buccal epithelium

PROCEDURE

Biospecimen collection

Undergo collection of blood

PROCEDURE

Biospecimen collection

Undergo collection of urine

PROCEDURE

Pulmonary Function Test

Undergo pulmonary function test

PROCEDURE

Computed Tomography (CT)

Undergo chest CT

OTHER

Laboratory Biomarker

Correlative studies

Trial Locations (1)

37232

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt-Ingram Cancer Center

OTHER

NCT03181256 - Early Detection of Lung Cancer | Biotech Hunter | Biotech Hunter